A Multi-part, Double Blind Study to Assess Safety, Tolerability & Efficacy

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06051617` - Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis	Phase 3
Recruiting	`NCT06060665` - IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)	Phase 3
Recruiting	`NCT05450887` - Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis	Phase 3
Recruiting	`NCT05050136` - A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis	Phase 2
Recruiting	`NCT04076527` - Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis
Recruiting	`NCT05151809` - National Database on Primary Biliary Cholangitis
Recruiting	`NCT04950764` - An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)	Phase 1
Completed	`NCT03545672` - Early Identification of Myocardial Impairment in PBC
Completed	`NCT06098027` - Study of [14C]CS0159 in China Healthy Subjects	Phase 1
Active, not recruiting	`NCT04594694` - Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC	Phase 2
Completed	`NCT03602560` - ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)	Phase 3
Suspended	`NCT03684187` - Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis	N/A
Recruiting	`NCT04617561` - Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II	Phase 4
Terminated	`NCT03092765` - Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid	Phase 2
Completed	`NCT04604652` - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis	Phase 2
Recruiting	`NCT05919433` - Detection Program for Patients With Primary Biliary Cholangitis Lost in the System
Completed	`NCT06309589` - The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis	N/A
Completed	`NCT05292872` - Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
Withdrawn	`NCT05293938` - A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
Terminated	`NCT03742973` - A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA	Phase 2

NCT number	NCT02516605
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	September 9, 2015
Completion date	August 2, 2018

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms